The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study

April 27, 2015 updated by: Dr. Nazzareno Fagoni, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Post Traumatic Cerebral Infarction Increases Mortality and Morbidity in Patients With Moderate or Severe Head Trauma. The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide (Ghajar, 2000). With an estimated annual incidence of up to 500 per 100,000 population and more than 200 hospital admissions per 100,000 admissions in Europe each year, TBI is a major challenge to public health (Lingsma, 2010). Mortality and morbidity after TBI depend on several factors, either associated with patients characteristics, the cause of TBI, the neurological and general severity and secondary brain insults, the structural brain alterations as diagnosed at brain computed tomography (CT) (Rosenfeld, 2012).

The prognostic value of brain CT characteristics is well documented, including the status of basal cisterns, midline shift, the presence and type of intracranial lesions, and traumatic subarachnoid hemorrhage (Maas, 2008). Postraumatic cerebral ischemia, which includes functionally impaired yet still viable tissue, so-called ischemic penumbra, and irreversible cerebral infarction (PTCI), is frequent in patients who die after moderate or severe head trauma (Stocchetti, 2014).

Evidence of antemortem occurrence of PTCI is limited to three single-center retrospective studies, reporting a varying prevalence of 1.9%, 8% and 19.1% (Mirvis, 1990; Marino, 2006; Tawil, 2008). Increased intracranial pressure (ICP), blunt cerebral vascular injury, need for craniotomy and treatment with recombinant activated factor VII, have been demonstrated to be risk factors for PTCI. In one study, PTCI was an independent risk factor for poor outcome after moderate or severe head trauma with a two-fold increase in mortality and severe disability (Marino, 2006).

PTCI can be an important diagnosis in patients with significant TBI for various reasons. First, it might influence long-term outcome. Second, as an outcome that is measurable, and relevant to survival and lifestyle, PTCI could be used as an outcome measure in randomized controlled trials. Third, diagnosis of PTCI could be used as a standard diagnostic reference to validate early surrogate indicators of cerebral ischemia.

The investigators therefore planned a multi-center prospective study to investigate the impact of PTCI on disability at hospital discharge, and on 6-month morbidity and mortality in a population of moderate and severe adult TBI patients. The investigators also evaluated the role of intracranial hypertension, decreased cerebral perfusion pressure, hypotension and other secondary ischemic insults in determining the appearance of PTCI.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

143

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brescia, Italy, 25123
        • Azienda Ospedaliera Spedali Civili di Brescia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with moderate or severe brain injury, monitored with invasive intracranial pressure.

Description

Inclusion Criteria:

  • age >15 years old,
  • with moderate or severe head trauma (GCS <14),
  • admitted to ICU. Cases were classified as severe head injury (GCS score < 9), or moderate head injury (GCS score from 9 to 13).

All patients recruited were monitored by means of invasive intracranial pressure (ICP), invasive arterial pressure monitoring, peripheral oxygen saturation, in accordance with published international and local guidelines

Exclusion Criteria:

  • age <16 years old,
  • mild head trauma,
  • absence of invasive ICP or invasive arterial pressure monitoring,
  • dying patients,
  • absence of brain stem reflexes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TBI, no cerebral infarction
patients with moderate or severe brain injury that do not develop posttraumatic cerebral infarction
TBI, posttraumatic cerebral infarction
patients with moderate or severe brain injury that develops posttraumatic cerebral infarction
the difference between groups refers to the developing of cerebral infarction after traumatic brain injury

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxford Handicap Scale (OHS)
Time Frame: patients will be evaluated at hospital discharge, an expected average of 3 weeks

The Oxford Handicap Scale evaluates the outcome as follow: 0 no symptoms, 1 minor symptoms, 2 minor handicap, 3 moderate handicap, 4 severe handicap, 5 death.

Favourable outcome: 0-3; unfavourable outcome: 4-5

patients will be evaluated at hospital discharge, an expected average of 3 weeks
Glasgow Outcome Scale (GOS)
Time Frame: the GOS will be performed 6 months after the hospital admission

The Glasgow Outcome Scale evaluates the outcome as follow: 1 death, 2 vegetative state, 3 severe handicap, 4 moderate handicap, 5 good recovery.

Favourable outcome: 4-5; unfavourable outcome: 1-3

the GOS will be performed 6 months after the hospital admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital and ICU mortality
Time Frame: at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks
This outcome refers to the mortality during ICU stay and hospital stay
at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks
Length of ventilation
Time Frame: during ICU stay, an expected average of 3 weeks
Days of ventilation, how long does it take to weaning from ventilation
during ICU stay, an expected average of 3 weeks
Length of ICU and Hospital stay
Time Frame: at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks
How many days the patients whith cerebral infarction and without cerebral infarction have been in ICU, and how many days the patients were in hospital
at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2009

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

April 16, 2015

First Submitted That Met QC Criteria

April 27, 2015

First Posted (Estimate)

April 30, 2015

Study Record Updates

Last Update Posted (Estimate)

April 30, 2015

Last Update Submitted That Met QC Criteria

April 27, 2015

Last Verified

April 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on TBI (Traumatic Brain Injury)

Clinical Trials on posttraumatic cerebral infarction

3
Subscribe